Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific nucleophilic sites on DNA, RNA, and proteins refer to electron-rich atoms—primarily nitrogen, oxygen, and sulfur—that serve as targets for highly reactive electrophilic compounds (StatPearls, NBK541111). In the context of oncology, these sites are the primary targets for}
Drugs targeting these sites act by forming highly reactive electrophilic intermediates that undergo nucleophilic attack by atoms such as the N7 of guanine in DNA or sulfur in protein cysteine residues (StatPearls, NBK541111). This covalent binding results in DNA adducts, interstrand and intrastrand cross-links, and protein-DNA cross-links, which physically obstruct DNA replication and transcription (PubMed, 1550693). The resulting genomic instability and cellular stress trigger apoptotic pathways, particularly in rapidly dividing cells (PubChem, CID 2907).
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific nucleophilic sites on DNA, RNA, and proteins.